Authors:
Imamichi, T
Murphy, MA
Imamichi, H
Lane, HC
Citation: T. Imamichi et al., Amino acid deletion at codon 67 and Thr-to-Gly change at codon 69 of humanimmunodeficiency virus type 1 reverse transcriptase confer novel drug resistance profiles, J VIROLOGY, 75(8), 2001, pp. 3988-3992
Citation: L. Ma et al., Genetic divergence of the dihydrofolate reductase and dihydropteroate synthase genes in Pneumocystis carinii from 7 different host species, J INFEC DIS, 184(10), 2001, pp. 1358-1362
Authors:
Imamichi, H
Crandall, KA
Natarajan, V
Jiang, MK
Dewar, RL
Berg, S
Gaddam, A
Bosche, M
Metcalf, JA
Davey, RT
Lane, HC
Citation: H. Imamichi et al., Human immunodeficiency virus type 1 quasi species that rebound after discontinuation of highly active antiretroviral therapy are similar to the viralquasi species present before initiation of therapy, J INFEC DIS, 183(1), 2001, pp. 36-50
Authors:
de Quiros, JCLB
Shupert, WL
McNeil, AC
Gea-Banacloche, JC
Flanigan, M
Savage, A
Martino, L
Weiskopf, EE
Imamichi, H
Zhang, YM
Adelsburger, J
Stevens, R
Murphy, PM
Zimmerman, PA
Hallahan, CW
Davey, RT
Connors, M
Citation: Jclb. De Quiros et al., Resistance to replication of human immunodeficiency virus challenge in SCID-Hu mice engrafted with peripheral blood mononuclear cells of nonprogressors is mediated by CD8(+) T cells and associated with a proliferative response to p24 antigen, J VIROLOGY, 74(4), 2000, pp. 2023-2028
Authors:
Imamichi, T
Berg, SC
Imamichi, H
Lopez, JC
Metcalf, JA
Falloon, J
Lane, HC
Citation: T. Imamichi et al., Relative replication fitness of a high-level 3 '-azido-3 '-deoxythymidine-resistant variant of human immunodeficiency virus type 1 possessing an amino acid deletion at codon 67 and a novel substitution (Thr -> Gly) at codon 69, J VIROLOGY, 74(23), 2000, pp. 10958-10964
Authors:
Imamichi, T
Sinha, T
Imamichi, H
Zhang, YM
Metcalf, JA
Falloon, J
Lane, HC
Citation: T. Imamichi et al., High-level resistance to 3 '-azido-3 '-deoxythimidine due to a deletion inthe reverse transcriptase gene of human immunodeficiency virus type 1, J VIROLOGY, 74(2), 2000, pp. 1023-1028
Authors:
Kovacs, JA
Imamichi, H
Vogel, S
Metcalf, JA
Dewar, RL
Baseler, M
Stevens, R
Adelsberger, J
Lambert, L
Davey, RT
Walker, RE
Falloon, J
Polis, MA
Masur, H
Lane, HC
Citation: Ja. Kovacs et al., Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expression, J INFEC DIS, 182(4), 2000, pp. 1063-1069
Authors:
Crandall, KA
Kelsey, CR
Imamichi, H
Lane, HC
Salzman, NP
Citation: Ka. Crandall et al., Parallel evolution of drug resistance in HIV: Failure of nonsynonymous/synonymous substitution rate ratio to detect selection, MOL BIOL EV, 16(3), 1999, pp. 372-382